KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Royalty Pharma (RPRX) Divestments (2023 - 2025)

Historic Divestments for Royalty Pharma (RPRX) over the last 3 years, with Q4 2025 value amounting to $5.0 million.

  • Royalty Pharma's Divestments rose 5394.57% to $5.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $105.1 million, marking a year-over-year increase of 34477.39%. This contributed to the annual value of $105.1 million for FY2025, which is 34477.39% up from last year.
  • As of Q4 2025, Royalty Pharma's Divestments stood at $5.0 million, which was up 5394.57% from $905000.0 recorded in Q3 2025.
  • In the past 5 years, Royalty Pharma's Divestments registered a high of $63.0 million during Q2 2025, and its lowest value of $905000.0 during Q3 2025.
  • Over the past 3 years, Royalty Pharma's median Divestments value was $5.0 million (recorded in 2024), while the average stood at $15.7 million.
  • Data for Royalty Pharma's Divestments shows a peak YoY increase of 149746.39% (in 2025) and a maximum YoY decrease of 9212.29% (in 2025) over the last 5 years.
  • Over the past 3 years, Royalty Pharma's Divestments (Quarter) stood at $4.7 million in 2023, then crashed by 30.34% to $3.2 million in 2024, then soared by 53.95% to $5.0 million in 2025.
  • Its last three reported values are $5.0 million in Q4 2025, $905000.0 for Q3 2025, and $63.0 million during Q2 2025.